Overview
- Martin Shkreli's lifetime ban from the pharmaceutical industry was upheld by a federal appeals court, which ruled that the ban was a reasonable measure to protect the public from future price-fixing.
- Shkreli was ordered to repay $64.6 million for his role in orchestrating an illegal anticompetitive scheme, which involved increasing the price of the antiparasitic drug Daraprim by 4,000%.
- New York Attorney General Letitia James cited the ruling in her case against former President Donald Trump, in which she is seeking a lifetime ban for Trump from the New York real estate industry.
- James is alleging that Trump and his associates fraudulently inflated the former president's assets by billions of dollars on statements of financial condition.
- The case against Trump is still pending, with the judge yet to issue a ruling on the attorney general's request.